MBX vs. CNTA

Last updated Jul 29, 2026

MBX (MBX Biosciences, Inc) and CNTA (Centessa Pharmaceuticals Limited) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Their 0.24 correlation means their historical movements had little consistent relationship.

Performance

MBX vs. CNTA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in MBX Biosciences, Inc (MBX) and Centessa Pharmaceuticals Limited (CNTA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

MBX

• 1D: -2.02%
• 1M: 14.82%
• 6M: 66.51%
• YTD: 90.42%
• 1Y: 312.78%
• 3Y*: —
• 5Y*: —
• 10Y*: —
• ALL TIME*: 67.08%

CNTA

• 1D: —
• 1M: —
• 6M: —
• YTD: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —
• ALL TIME*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
MBX MBX Biosciences, Inc	$41.37M	$49.23M	$38.55M

MBX vs. CNTA - Yearly Performance Comparison

	2026 (YTD)	2025	2024
MBX MBX Biosciences, Inc	90.42%	71.13%	-19.87%
CNTA Centessa Pharmaceuticals Limited	61.94%	49.31%	10.93%

Correlation

The correlation between MBX and CNTA is 0.23, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.23
Correlation (All Time) Calculated using the full available price history since Sep 13, 2024	0.24

Fundamentals

EPS MBX : -$2.22 CNTA : -$1.81
Total Revenue (TTM) MBX : $0.00 CNTA : $15.00M
Gross Profit (TTM) MBX : -$160.00K CNTA : $15.00M
EBITDA (TTM) MBX : -$96.31M CNTA : -$227.27M

Return for Risk

MBX vs. CNTA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MBX

MBX Risk / Return Rank: 96
MBX Sharpe Ratio Rank: 95
MBX Sortino Ratio Rank: 97
MBX Omega Ratio Rank: 95
MBX Calmar Ratio Rank: 98
MBX Martin Ratio Rank: 96

CNTA

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MBX vs. CNTA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for MBX Biosciences, Inc (MBX) and Centessa Pharmaceuticals Limited (CNTA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	MBX	CNTA	Difference
Sharpe ratio: Return per unit of total volatility	2.36	—	—
Sortino ratio: Return per unit of downside risk	3.84	—	—
Omega ratio: Gain probability vs. loss probability	1.45	—	—
Calmar ratio: Return relative to maximum drawdown	8.38	—	—
Martin ratio: Return relative to average drawdown	16.02	—	—

Drawdowns

Drawdown Indicators

	MBX	CNTA	Difference
Max Drawdown Largest peak-to-trough decline	-77.71%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-37.60%	—	—
Current Drawdown Current decline from peak	-8.60%	—	—
Average Drawdown Average peak-to-trough decline	-32.88%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	19.63%	—	—

Volatility

Volatility by Period

	MBX	CNTA	Difference
Volatility (1M) Calculated over the trailing 1-month period	21.51%	—	—
Volatility (6M) Calculated over the trailing 6-month period	54.09%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	133.39%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	116.74%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	116.74%	—	—

Dividends

MBX vs. CNTA - Dividend Comparison

Neither MBX nor CNTA has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both MBX and CNTA in my portfolio?

MBX and CNTA have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.